deltatrials
Unknown PHASE1 INTERVENTIONAL 2-arm NCT03921879

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

A Phase 1 Study of OT-82 in Patients With Relapsed or Refractory Lymphoma

Sponsor: Oncotartis, Inc.

Conditions Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, T-Cell
Interventions OT-82 Dose Escalation OT-82 Dose Expansion
Updated 10 times since 2019 Last updated: Oct 22, 2020 Started: Jul 29, 2019 Primary completion: Apr 30, 2021 Completion: Jun 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Lymphoma and Lymphoma, B-Cell and is currently ongoing. Oncotartis, Inc. leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2019 – ~Oct 2019 · 5 months · monthly snapshotNot Yet Recruiting~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshotRecruiting~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshotRecruiting~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshotRecruiting~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotRecruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Nov 2022 [monthly]

    Recruiting PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

▶ Show 5 earlier versions

  1. Apr 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  2. Feb 2020 — Apr 2020 [monthly]

    Recruiting PHASE1

  3. Nov 2019 — Feb 2020 [monthly]

    Recruiting PHASE1

  4. Oct 2019 — Nov 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. May 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oncotartis, Inc.
Data source: Oncotartis, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations